Float Short %

10.95

Margin Of Safety %

Put/Call OI Ratio

0.5

EPS Next Q Diff

-0.17

EPS Last/This Y

-0.89

EPS This/Next Y

-0.52

Price

32.51

Target Price

125.75

Analyst Recom

Performance Q

-53.2

Relative Volume

0.6

Beta

1.19

Ticker: PCVX

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-06-02	PCVX	35.01	0.44	0.10	6638
2025-06-03	PCVX	34.65	0.44	2.53	6657
2025-06-04	PCVX	33.86	0.44	0.15	6677
2025-06-05	PCVX	34.64	0.45	0.20	6682
2025-06-06	PCVX	36.99	0.45	0.05	6686
2025-06-09	PCVX	37.2	0.45	0.08	6680
2025-06-10	PCVX	37.16	0.45	2.45	6692
2025-06-11	PCVX	35.56	0.46	10.38	6763
2025-06-12	PCVX	34.46	0.52	11.00	7060
2025-06-13	PCVX	34.56	0.52	0.54	7072
2025-06-16	PCVX	34.35	0.53	2.76	7081
2025-06-17	PCVX	33.65	0.54	3.00	7164
2025-06-18	PCVX	33.43	0.54	0.00	7164
2025-06-20	PCVX	32.87	0.54	0.04	7163
2025-06-23	PCVX	33.25	0.50	0.03	6854
2025-06-24	PCVX	34.09	0.50	0.00	6882
2025-06-25	PCVX	33.05	0.50	0.00	6892
2025-06-26	PCVX	32.88	0.50	0.25	6893
2025-06-27	PCVX	32.58	0.50	0.00	6934
2025-06-30	PCVX	32.53	0.50	0.00	6934
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-06-02	PCVX	35.02	-5.8	-	-4.69
2025-06-03	PCVX	34.65	-5.8	-	-4.69
2025-06-04	PCVX	33.87	-5.8	-	-4.69
2025-06-05	PCVX	34.80	-5.8	-	-4.69
2025-06-06	PCVX	36.98	-5.8	-	-4.69
2025-06-09	PCVX	37.20	-5.8	-	-4.69
2025-06-10	PCVX	37.18	-5.8	-	-4.69
2025-06-11	PCVX	35.44	-5.8	-	-4.69
2025-06-12	PCVX	34.46	-5.8	-	-4.69
2025-06-13	PCVX	34.52	-5.8	-	-4.69
2025-06-16	PCVX	34.35	-5.8	-	-4.69
2025-06-17	PCVX	33.66	-5.8	-	-4.69
2025-06-18	PCVX	33.40	-5.8	-	-4.69
2025-06-20	PCVX	32.87	-5.8	-	-4.69
2025-06-23	PCVX	33.26	-5.8	-	-4.69
2025-06-24	PCVX	34.08	-5.8	-	-4.69
2025-06-25	PCVX	33.06	-5.8	-	-4.69
2025-06-26	PCVX	32.89	-5.8	-	-4.69
2025-06-27	PCVX	32.56	-5.8	-	-4.69
2025-06-30	PCVX	32.51	-5.8	-	-4.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	PCVX	-2.47	6.19	10.79
2025-06-03	PCVX	-2.47	6.19	10.79
2025-06-04	PCVX	-1.91	6.19	10.79
2025-06-05	PCVX	-1.91	6.19	10.79
2025-06-06	PCVX	-1.91	6.19	10.79
2025-06-09	PCVX	-1.91	6.36	10.79
2025-06-10	PCVX	-1.79	6.36	10.79
2025-06-11	PCVX	-1.73	6.36	10.56
2025-06-12	PCVX	-1.73	6.36	10.56
2025-06-13	PCVX	-1.73	6.36	10.56
2025-06-16	PCVX	-1.73	6.55	10.56
2025-06-18	PCVX	-1.73	6.55	10.56
2025-06-20	PCVX	-1.53	6.55	10.56
2025-06-23	PCVX	-1.53	6.35	10.56
2025-06-24	PCVX	-1.52	6.35	10.56
2025-06-25	PCVX	-1.52	6.35	10.56
2025-06-26	PCVX	-1.52	6.35	10.96
2025-06-27	PCVX	-1.52	6.35	10.96
2025-06-30	PCVX	-1.52	6.44	10.95
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.04

Avg. EPS Est. Current Quarter

-1.16

Avg. EPS Est. Next Quarter

-1.21

Insider Transactions

-1.52

Institutional Transactions

6.44

Beta

1.19

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

73.1

Max Drawdown 5-Year %

-76.2

Target Price

125.75

P/E

Forward P/E

PEG

P/S

P/B

1.31

P/Free Cash Flow

EPS

-4.07

Average EPS Est. Cur. Y

-4.69

EPS Next Y. (Est.)

-5.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.6

Return on Equity vs Sector %

-39.8

Return on Equity vs Industry %

-20.6

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.41

EBIT Estimation

Vaxcyte, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 414

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

stock quote shares PCVX – Vaxcyte, Inc. Stock Price stock today

news today PCVX – Vaxcyte, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PCVX – Vaxcyte, Inc. yahoo finance google finance

stock history PCVX – Vaxcyte, Inc. invest stock market

stock prices PCVX premarket after hours

ticker PCVX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PCVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y